EPITERNA

EPITERNA

Biotechnologieforschung

Creating more time that matters for pets and people

Info

We are a growing team of ambitious scientists, engineers, veterinarians and doctors based in Europe and we are passionate about life extending science. We understand that our mission will not be simple or quick, but we are determined to create more time that matters for people and their pets. Ageing is one of the greatest challenges of our time. As the major risk factor for diseases and functional decline, it is at the root of the most devastating health problems we face. Science has demonstrated that we can slow the ageing process and extend the lives of animals in the laboratory. EPITERNA was founded to translate these discoveries into longer, healthier and happier lives – for companion dogs and cats, and for people. Our team develops affordable products that can safely slow the ageing process to prevent age-related disease, delay functional decline, and extend life.

Branche
Biotechnologieforschung
Größe
11–50 Beschäftigte
Hauptsitz
Switzerland
Art
Privatunternehmen
Gegründet
2022

Orte

Beschäftigte von EPITERNA

Updates

Ähnliche Seiten

Finanzierung

EPITERNA Insgesamt 1 Finanzierungsrunde

Letzte Runde

Unternehmensrunde

11.007.700,00 $

Investor:innen

Prima Materia
Weitere Informationen auf Crunchbase